Wikidata

(Q61956950)

English

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

clinical trial

In more languages

Statements

title
Safety, Clinical Tolerability and Immunogenicity of gpASIT+TM Administered Subcutaneously to Hay Fever Patients Either Alone or in Presence of DnaK Immunoregulating Adjuvant (English)
0 references
medical condition
fever
0 references
country
Belgium
0 references
start time
November 2011
0 references
end time
January 2013
0 references
number of participants
24
0 references
minimum age
18 year
0 references
maximum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61956950&oldid=2074996039"